Skip to content
Nonprofiteer
← All organizations

NOVO NORDISK FONDEN

EIN 98-1718091 DENMARK

Revenue 2024
$1,362,313,838
Expenses 2024
$1,252,266,819

Program services were 95.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

As filed

Subsection
04
NTEE code
T12
Classification
3000
Street
HELLERUP 2900

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Other organizations at this address

1 other organization in the IRS Business Master File lists the same street address. matched by us

We match the street line and ZIP code as the IRS gives them, ignoring case and outer spaces and nothing else, so "AVE" and "AVENUE" count as different streets and this list can miss some. A shared address can mean related organizations or a shared office, but it can also be a registered agent, a mail drop or a service provider holding mail for unrelated clients. It is not, by itself, evidence that two organizations are connected.

Mission and programs · 2024

Mission

NOVO NORDISK FONDEN (NNF) CONTRIBUTES SIGNIFICANTLY TO RESEARCH AND DEVELOPMENT THAT IMPROVES THE LIVES OF PEOPLE AND THE SUSTAINABILITY OF SOCIETY THROUGH GRANTMAKING.

  • NNF FOCUSES ITS GRANTMAKING PROGRAM TOWARD 3 MAIN OBJECTIVES:1. TO SUPPORT PHYSIOLOGICAL, ENDOCRINOLOGICAL, METABOLIC, AND OTHER MEDICAL RESEARCH. FOR 2024, 25% OF GRANTS WERE AWARDED FOR MEDICAL RESEARCH.2. TO SUPPORT RESEARCH HOSPITAL ACTIVITIES RELATED TO DIABETES IN DENMARK. FOR 2024, 0% OF GRANTS WERE AWARDED FOR RESEARCH HOSPITAL ACTIVITIES.3. TO SUPPORT OTHER SCIENTIFIC, HUMANITARIAN, AND SOCIAL PURPOSES. FOR 2024, 75% OF GRANTS WERE AWARDED FOR SUCH OTHER PURPOSES.

    Expenses $1,200,845,149 · Grants $1,171,517,714

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

  • Steen Riisgaard

    DIRECTOR

    Total calculated
    $413,317
    From this org
    $223,624
    From related orgs
    $189,693
    Other
    $0
    Hours/week
    1 + 1 related

    Schedule J breakdown matched by us

    Base
    $60,329 + $173,467 related
    Bonus
    $0
    Other
    $163,295 + $16,226 related
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $223,624 + $189,693 related

  • Mads Boritz Gron

    DIRECTOR

    Total calculated
    $71,206
    From this org
    $71,206
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Stig Strobaek

    DIRECTOR

    Total calculated
    $71,206
    From this org
    $71,206
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Lars Henrik Fugger

    DIRECTOR

    Total calculated
    $122,688
    From this org
    $122,688
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Liselotte Hojgaard

    DIRECTOR

    Total calculated
    $85,708
    From this org
    $85,708
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Nana Sejbaek

    DIRECTOR

    Total calculated
    $86,289
    From this org
    $86,289
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Ole Jakob Muller

    DIRECTOR

    Total calculated
    $71,206
    From this org
    $71,206
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Christopher Ashby Voigt

    DIRECTOR

    Total calculated
    $103,691
    From this org
    $103,691
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

  • Lars Rebien Sorensen

    CHAIR

    Total calculated
    $672,365
    From this org
    $374,302
    From related orgs
    $298,063
    Other
    $0
    Hours/week
    1 + 1 related

    Schedule J breakdown matched by us

    Base
    $271,481 + $260,200 related
    Bonus
    $0
    Other
    $102,821 + $37,863 related
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $374,302 + $298,063 related

  • Lars Henrik Munch

    VICE CHAIR

    Total calculated
    $172,431
    From this org
    $172,431
    From related orgs
    $0
    Other
    $0
    Hours/week
    1

    Schedule J breakdown matched by us

    Base
    $150,823
    Bonus
    $0
    Other
    $21,608
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $172,431

  • Mads Krogsgaard Thomsen

    CEO

    Total calculated
    $1,598,724
    From this org
    $1,284,200
    From related orgs
    $0
    Other
    $314,524
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $887,071
    Bonus
    $371,025
    Other
    $26,104
    Deferred
    $314,524
    Nontaxable benefits
    $0
    Filer's total
    $1,598,724

  • Erika Soderberg Johnsson

    CFO

    Total calculated
    $452,991
    From this org
    $452,991
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $430,368
    Bonus
    $0
    Other
    $22,623
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $452,991

  • Soren Nedergaard

    COO

    Total calculated
    $560,766
    From this org
    $495,106
    From related orgs
    $0
    Other
    $65,660
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $325,430
    Bonus
    $143,572
    Other
    $26,104
    Deferred
    $65,660
    Nontaxable benefits
    $0
    Filer's total
    $560,766

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

  • 2024
    Revenue
    $1,362,313,838
    Expenses
    $1,252,266,819
    Contributions
    $0
    Grants paid
    $1,171,517,714
  • 2023
    Revenue
    $225,759,846
    Expenses
    $1,186,935,341
    Contributions
    $0
    Grants paid
    $1,124,503,169

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Grants made

The 10 largest by cash amount. The API serves every itemized grant.

Where these grants went next →

Grants received

No itemized grant names this organization as a recipient. Only grants over $5,000 are itemized, and only by filers of the full Form 990.

Related organizations

From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.

Declared on its 2024 return

Declared as related by

Taxable family

From Schedule R Parts I, III and IV: entities that legally are the filer, and taxable partnerships, corporations and trusts it is related to. These record ownership and control, not shared board members or money.

Related partnerships on its 2024 return

  • NH KRONOS ULTIMATE HOLDINGS LP

    LIFE SCIENCES · MA

  • NH KRONOS HOLDINGS LP

    LIFE SCIENCES · MA

  • MAIA AGGREGATOR LP

    LIFE SCIENCES · MA

  • NOVO MAIA LP

    LIFE SCIENCES · MA

  • NOVO VENTURES 1 PS

    LIFE SCIENCES · DA

  • NOVO CAPITAL INVESTORS PS

    LIFE SCIENCES · DA

  • NOVO NORDISK PHARMACEUTICAL INDUSTRIES LP

    LIFE SCIENCES · NC

  • NOVO RHEA AGGREGATOR LP

    LIFE SCIENCES · MA

  • RHEA ACQUISITION HOLDINGS LP

    LIFE SCIENCES · MA

  • RHEA INTERMEDIATE LP

    LIFE SCIENCES · MA

  • EJENDOMSSELSKABET NOVO HOLDINGS PS

    LIFE SCIENCES · DA

  • QUANTUM FOUNDRY PS

    RELATED · LIFE SCIENCES · DA · 100% owned · share of income -$3,234,283 · share of assets $17,054,908 · general or managing partner

  • NOVO NORDISK FOUNDATION CELLERATOR PS

    RELATED · LIFE SCIENCES · DA · 100% owned · share of income -$1,345,370 · share of assets $33,752,041 · general or managing partner

  • NVAC PS

    RELATED · LIFE SCIENCES · DA · 100% owned · share of income -$883,040 · share of assets $531,919 · general or managing partner

  • NH AIFM PS (NOVO INVEST F2PS)

    LIFE SCIENCES · DA

  • NOVO HOLDINGS BUSINESS & PEOPLE SUPPORT PS

    LIFE SCIENCES · DA

  • NOVO HOLDINGS DK INVESTMENT ADVISOR PS

    LIFE SCIENCES · DA

  • CREEK HOLDINGS LP

    LIFE SCIENCES · MA

  • CREEK FEEDER LP

    LIFE SCIENCES · MA

Related corporations and trusts on its 2024 return

  • NOVO NORDISK AS

    C · LIFE SCIENCES · DA · controlled entity

  • ALDAPH SPA

    C · LIFE SCIENCES · AG · controlled entity

  • BEIJING NOVO NORDISK PHARMACEUTICALS SCIENCE AND TECHNOLOGY

    C · LIFE SCIENCES · CH · controlled entity

  • CORVIDIA THERAPEUTICS INC

    C · LIFE SCIENCES · MA · controlled entity

  • DICERNA PHARMACEUTICALS INC

    C · LIFE SCIENCES · KY · controlled entity

  • EMISPHERE TECHNOLOGIES INC

    C · LIFE SCIENCES · NJ · controlled entity

  • FORMA THERAPEUTICS INC

    C · LIFE SCIENCES · DA · controlled entity

  • NN PANAMA

    C · LIFE SCIENCES · PM · controlled entity

  • NNE PHARMAPLAN AS

    C · LIFE SCIENCES · DA · controlled entity

  • NNE PHARMAPLAN AS - UNITED STATES PE

    C · LIFE SCIENCES · NC · controlled entity

  • NNE PHARMAPLAN AB

    C · LIFE SCIENCES · SW · controlled entity

  • NNE PHARMAPLAN INC

    C · LIFE SCIENCES · NC · controlled entity

  • NNE PHARMAPLAN INDIA LIMITED

    C · LIFE SCIENCES · IN · controlled entity

  • NNE PHARMAPLAN OOO

    C · LIFE SCIENCES · RS · controlled entity

  • NOVO INVESTMENTS PTE LIMITED

    C · LIFE SCIENCES · SN · controlled entity

  • NOVO NORDISK (CHINA) PHARMACEUTICALS CO LTD

    C · LIFE SCIENCES · CH · controlled entity

  • NOVO NORDISK (PTY) LIMITED

    C · LIFE SCIENCES · SF · controlled entity

  • NOVO NORDISK (SHANGHAI) HOLDING CO LTD

    C · LIFE SCIENCES · CH · controlled entity

  • NOVO NORDISK (SHANGHAI) PHARMA TRADING CO LTD

    C · LIFE SCIENCES · CH · controlled entity

  • NOVO NORDISK BV

    C · LIFE SCIENCES · NL · controlled entity

  • NOVO NORDISK BIOPHARM LIMITED

    C · LIFE SCIENCES · DA · controlled entity

  • NOVO NORDISK CANADA INC

    C · LIFE SCIENCES · CA · controlled entity

  • NOVO NORDISK COLOMBIA SAS

    C · LIFE SCIENCES · CO · controlled entity

  • NOVO NORDISK COMERCIO PRODUTOS FARMACEUTICOS LDA

    C · LIFE SCIENCES · PO · controlled entity

  • NOVO NORDISK DOO

    C · LIFE SCIENCES · SI · controlled entity

The first 25 as filed. The return lists the rest.

Other IRS files

Auto-Revocation List

Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.

Publication 78

Not present in the most recent drop.

These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.

What this page reflects

The registration facts above come from the IRS Business Master File published 9 November 2026 and read 9 November 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.